HRAS Detection Assay

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to TherapyNCT03719690KURAPhase 2Completed2023-05-02Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.